Disruption of the interaction between RAS and PI3Kα using a novel protein:protein interaction inhibitor suppressed PI3Kα-AKT activation and increased the tumor response to sotorasib to a similar level as BBO-8520. The gene discussed is AKT1; the disease is neoplasm.